标题
Anti-Pseudomonas aeruginosa Vaccines and Therapies: An Assessment of Clinical Trials
作者
关键词
-
出版物
Microorganisms
Volume 11, Issue 4, Pages 916
出版商
MDPI AG
发表日期
2023-03-31
DOI
10.3390/microorganisms11040916
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Synergy between Human Peptide LL-37 and Polymyxin B against Planktonic and Biofilm Cells of Escherichia coli and Pseudomonas aeruginosa
- (2023) Kylen E. Ridyard et al. Antibiotics-Basel
- Persistence and genetic adaptation of Pseudomonas aeruginosa in patients with chronic obstructive pulmonary disease
- (2022) Josefin Eklöf et al. CLINICAL MICROBIOLOGY AND INFECTION
- Effect of therapeutic drug monitoring-based dose optimization of piperacillin/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trial
- (2022) Stefan Hagel et al. INTENSIVE CARE MEDICINE
- Structure activity relationship of N-1 substituted 1,5-naphthyrid-2-one analogs of oxabicyclooctane-linked novel bacterial topoisomerase inhibitors as broad-spectrum antibacterial agents (Part-9)
- (2022) Sheo B. Singh et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Comparison of 8 versus 15 days of antibiotic therapy for Pseudomonas aeruginosa ventilator-associated pneumonia in adults: a randomized, controlled, open-label trial
- (2022) Adrien Bouglé et al. INTENSIVE CARE MEDICINE
- The effects of antibiotic cycling and mixing on acquisition of antibiotic resistant bacteria in the ICU: A post-hoc individual patient analysis of a prospective cluster-randomized crossover study
- (2022) Pleun J. van Duijn et al. PLoS One
- Blood mRNA biomarkers distinguish variable systemic and sputum inflammation at treatment initiation of inhaled antibiotics in cystic fibrosis: A prospective non-randomized trial
- (2022) Silvia M. Caceres et al. PLoS One
- Efficacy and Safety of Ciprofloxacin Plus Fluocinolone Acetonide Among Patients With Acute Otitis Externa
- (2022) Laurence Chu et al. JAMA Network Open
- Targeted AntiBiotics for Chronic pulmonary diseases (TARGET ABC): can targeted antibiotic therapy improve the prognosis of Pseudomonas aeruginosa-infected patients with chronic pulmonary obstructive disease, non-cystic fibrosis bronchiectasis, and asthma? A multicenter, randomized, controlled, open-label trial
- (2022) Josefin Eklöf et al. Trials
- Distribution and Characteristics of Bacteria Isolated from Cystic Fibrosis Patients with Pulmonary Exacerbation
- (2022) Soroor Erfanimanesh et al. Canadian Journal of Infectious Diseases & Medical Microbiology
- A Double-Blind Randomized Placebo-Controlled Phase 3 Trial of Tobramycin Inhalation Solution in Adults With Bronchiectasis With Pseudomonas aeruginosa Infection
- (2022) Wei-jie Guan et al. CHEST
- Evaluating the emergence of nonsusceptibility among Pseudomonas aeruginosa respiratory isolates from a phase 3 clinical trial for treatment of nosocomial pneumonia (ASPECT-NP)
- (2021) Matthew G. Johnson et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Imipenem/cilastatin/relebactam: A new carbapenem β-lactamase inhibitor combination
- (2021) Hanine Mansour et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Pseudomonas aeruginosa device associated – healthcare associated infections and its multidrug resistance at intensive care unit of University Hospital: polish, 8.5-year, prospective, single-centre study
- (2021) Agnieszka Litwin et al. BMC INFECTIOUS DISEASES
- Association of Intensity of Anti-Pseudomonal Antibiotic Therapy With Risk of Treatment-Emergent Organisms in Cystic Fibrosis Children with Newly Acquired Pseudomonas Aeruginosa
- (2021) Jonathan D Cogen et al. CLINICAL INFECTIOUS DISEASES
- Effect of povidone iodine contact lens disinfecting solution on orthokeratology lens and lens case contamination and organisms in the microbiome of the conjunctiva
- (2021) Sin Wan Cheung et al. Contact Lens & Anterior Eye
- Bacterial Re-Colonization Occurs Early after Lung Transplantation in Cystic Fibrosis Patients
- (2021) Anna Engell Holm et al. Journal of Clinical Medicine
- Single- and Multiple-Ascending-Dose Study of the Safety, Tolerability, and Pharmacokinetics of the Polymyxin Derivative SPR206
- (2021) Jon Bruss et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- New generation ENaC inhibitors detach cystic fibrosis airway mucus bundles via sodium/hydrogen exchanger inhibition
- (2021) Melania Giorgetti et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Is It Possible to Create Antimicrobial Peptides Based on the Amyloidogenic Sequence of Ribosomal S1 Protein of P. aeruginosa?
- (2021) Sergei Y. Grishin et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Long-term amikacin liposome inhalation suspension in cystic fibrosis patients with chronic P. aeruginosa infection
- (2021) Diana Bilton et al. Journal of Cystic Fibrosis
- Preclinical efficacy and clinical safety of clinical‐grade nebulized allogenic adipose mesenchymal stromal cells‐derived extracellular vesicles
- (2021) Meng‐meng Shi et al. Journal of Extracellular Vesicles
- Comparative Plasma and Interstitial Tissue Fluid Pharmacokinetics of Meropenem Demonstrate the Need for Increasing Dose and Infusion Duration in Obese and Non-obese Patients
- (2021) David Busse et al. CLINICAL PHARMACOKINETICS
- Intravenous or oral antibiotic treatment in adults and children with cystic fibrosis and Pseudomonas aeruginosa infection: the TORPEDO-CF RCT
- (2021) Simon C Langton Hewer et al. HEALTH TECHNOLOGY ASSESSMENT
- Safety and pharmacokinetics of Roscovitine (Seliciclib) in cystic fibrosis patients chronically infected with Pseudomonas aeruginosa, a randomized, placebo-controlled study
- (2021) Laurent Meijer et al. Journal of Cystic Fibrosis
- Testing the effects of combining azithromycin with inhaled tobramycin for P. aeruginosa in cystic fibrosis: a randomised, controlled clinical trial
- (2021) David P Nichols et al. THORAX
- Combining Ivacaftor and Intensive Antibiotics Achieves Limited Clearance of Cystic Fibrosis Infections
- (2021) Samantha L. Durfey et al. mBio
- In Vitro Activity of Ceftazidime-Avibactam Against Isolates from Respiratory and Blood Specimens from Patients with Nosocomial Pneumonia, including Ventilator-Associated Pneumonia, in a Phase 3 Clinical Trial
- (2020) Gregory G. Stone et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Imipenem‐Cilastatin‐Relebactam: A Novel β‐Lactam–β‐Lactamase Inhibitor Combination for the Treatment of Multidrug‐Resistant Gram‐Negative Infections
- (2020) Jordan R. Smith et al. PHARMACOTHERAPY
- Mechanism of Action of Surface Immobilized Antimicrobial Peptides Against Pseudomonas aeruginosa
- (2020) Muhammad Yasir et al. Frontiers in Microbiology
- Intraoperative application of inactivated Pseudomonas aeruginosa in patients undergoing lateral neck dissection for metastatic thyroid cancer: A randomized, parallel group, placebo-controlled trial
- (2020) Li Genpeng et al. SURGERY
- A Randomized, Double-blind, Multicenter Trial Comparing Efficacy and Safety of Imipenem/Cilastatin/Relebactam Versus Piperacillin/Tazobactam in Adults With Hospital-acquired or Ventilator-associated Bacterial Pneumonia (RESTORE-IMI 2 Study)
- (2020) Ivan Titov et al. CLINICAL INFECTIOUS DISEASES
- Outcomes in Participants with Renal Impairment from a Phase 3 Clinical Trial for Ceftolozane/Tazobactam Treatment of Nosocomial Pneumonia (ASPECT-NP)
- (2020) Jennifer A. Huntington et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacodynamic Evaluation of MRX-8, a Novel Polymyxin, in the Neutropenic Mouse Thigh and Lung Infection Models against Gram-Negative Pathogens
- (2020) Alexander J. Lepak et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Microbial epidemiology and risk factors for relapse in gram-negative bacteria catheter-related bloodstream infection with a pilot prospective study in patients with catheter removal receiving short-duration of antibiotic therapy
- (2020) Bhitta Surapat et al. BMC INFECTIOUS DISEASES
- Efficacy and safety of TOBI Podhaler® in Pseudomonas aeruginosa-infected bronchiectasis patients: iBEST study
- (2020) Michael R. Loebinger et al. EUROPEAN RESPIRATORY JOURNAL
- Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial
- (2020) Matteo Bassetti et al. LANCET INFECTIOUS DISEASES
- Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trial
- (2020) Richard G Wunderink et al. LANCET INFECTIOUS DISEASES
- Pseudomonas aeruginosa Biofilms
- (2020) Minh Tam Tran Thi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Role of Tris-CaEDTA as an adjuvant with nebulised tobramycin in cystic fibrosis patients with Pseudomonas aeruginosa lung infections: A randomised controlled trial
- (2020) Ramaa Puvvadi et al. Journal of Cystic Fibrosis
- Inhaled liposomal ciprofloxacin in patients with non-cystic fibrosis bronchiectasis and chronic lung infection with Pseudomonas aeruginosa (ORBIT-3 and ORBIT-4): two phase 3, randomised controlled trials
- (2019) Charles S Haworth et al. Lancet Respiratory Medicine
- The clinical efficacy of intravenous IgM-enriched immunoglobulin (pentaglobin) in sepsis or septic shock: a meta-analysis with trial sequential analysis
- (2019) Jie Cui et al. Annals of Intensive Care
- Antibiotic Therapy for Pseudomonas aeruginosa Bloodstream Infections: How Long is Long Enough?
- (2019) Valeria Fabre et al. CLINICAL INFECTIOUS DISEASES
- Pharmacokinetic-pharmacodynamic analysis of ciprofloxacin in elderly Chinese patients with lower respiratory tract infections caused by Gram-negative bacteria
- (2019) Xiao-Yan Gai et al. CHINESE MEDICAL JOURNAL
- Post-traumatic osteomyelitis in Middle East war-wounded civilians: resistance to first-line antibiotics in selected bacteria over the decade 2006–2016
- (2019) Fabien Fily et al. BMC INFECTIOUS DISEASES
- Characterization of β-lactamase content of ceftazidime-resistant pathogens recovered during the pathogen-directed Phase 3 trial (REPRISE) for ceftazidime-avibactam: Correlation of efficacy against β-lactamase producers
- (2019) Rodrigo E. Mendes et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- High incidence of multiresistant bacterial isolates from bloodstream infections in trauma emergency department and intensive care unit in Serbia
- (2019) Olivera Djuric et al. ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA
- Safety, Tolerability, Pharmacokinetics, and Drug Interaction Potential of SPR741, An Intravenous Potentiator, After Single and Multiple Ascending Doses and When Combined with Beta-Lactam Antibiotics in Healthy Subjects
- (2019) Paul B. Eckburg et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Randomized controlled study of aerosolized hypertonic xylitol versus hypertonic saline in hospitalized patients with pulmonary exacerbation of cystic fibrosis
- (2019) Sachinkumar Singh et al. Journal of Cystic Fibrosis
- Human antibody repertoire frequently includes antibodies to a bacterial biofilm associated protein
- (2019) Stefan Ryser et al. PLoS One
- RESTORE-IMI 1: A Multicenter, Randomized, Double-blind Trial Comparing Efficacy and Safety of Imipenem/Relebactam vs Colistin Plus Imipenem in Patients With Imipenem-nonsusceptible Bacterial Infections
- (2019) Johann Motsch et al. CLINICAL INFECTIOUS DISEASES
- Association of CFH polymorphism with susceptibility to sepsis caused by Pseudomonas aeruginosa in Chinese Han populations: A multi-center study
- (2019) Jia Li et al. GENE
- Amikacin liposome inhalation suspension for chronic Pseudomonas aeruginosa infection in cystic fibrosis
- (2019) Diana Bilton et al. Journal of Cystic Fibrosis
- Manuka honey sinus irrigations in recalcitrant chronic rhinosinusitis: phase 1 randomized, single‐blinded, placebo‐controlled trial
- (2019) Mian Li Ooi et al. International Forum of Allergy & Rhinology
- Polymyxin B analog SPR741 potentiates antibiotics against Gram-negative bacteria and uniquely perturbs the outer membrane
- (2019) Shawn French et al. ACS Infectious Diseases
- Changes in the prevalence of causative pathogens isolated from severe burn patients from 2012 to 2017
- (2019) Jin Ju Park et al. BURNS
- Microbiology and clinical characteristics of industrial oil burns
- (2019) Devin C. Kelly et al. BURNS
- Clinical and microbiological outcomes of photodynamic and systemic antimicrobial therapy in smokers with peri-implant inflammation
- (2019) Modhi Al Deeb et al. Photodiagnosis and Photodynamic Therapy
- Efficacy and safety of tobramycin inhalation powder in bronchiectasis patients with P. aeruginosa infection: Design of a dose-finding study (iBEST-1)
- (2019) Michael R. Loebinger et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Development of a novel hybrid antimicrobial peptide for targeted killing of Pseudomonas aeruginosa
- (2019) Hyun Kim et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Microbiology of Cystic Fibrosis Airway Disease
- (2019) Ana C. Blanchard et al. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
- The Role of Pseudomonas aeruginosa Lipopolysaccharide in Bacterial Pathogenesis and Physiology
- (2019) Steven M. Huszczynski et al. Pathogens
- Azithromycin for Early Pseudomonas Infection in Cystic Fibrosis: The Optimize Randomized Trial
- (2018) Nicole Mayer-Hamblett et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Pharmacokinetics of ciprofloxacin in children with complicated urinary tract infection: results of a multicenter population pharmacokinetic study.
- (2018) Kevin Meesters et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Activity of Ceftazidime-Avibactam against Isolates from Patients in a Phase 3 Clinical Trial for Treatment of Complicated Intra-abdominal Infections
- (2018) Gregory G. Stone et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antimicrobial Activity of Murepavadin Tested against Clinical Isolates of Pseudomonas aeruginosa from the United States, Europe, and China
- (2018) Helio S. Sader et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics and Safety of Intravenous Murepavadin Infusion in Healthy Adult Subjects Administered Single and Multiple Ascending Doses
- (2018) Achim Wach et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Murepavadin, a novel antipseudomonal antibiotic: Pharmacokinetics, tolerability and safety in subjects with mild, moderate, and severe renal function impairment
- (2018) Glenn E. Dale et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Intrapulmonary percussive ventilation improves lung function in cystic fibrosis patients chronically colonized with Pseudomonas aeruginosa: a pilot cross-over study
- (2018) Jozef Dingemans et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Burden and Risk Factors for Pseudomonas aeruginosa Community-acquired Pneumonia: a Multinational Point Prevalence Study of Hospitalised Patients
- (2018) Marcos I. Restrepo et al. EUROPEAN RESPIRATORY JOURNAL
- Murepavadin: a new antibiotic class in the pipeline
- (2018) Ignacio Martin-Loeches et al. Expert Review of Anti-Infective Therapy
- Urinary concentrations and antimicrobial activity of tobramycin in healthy volunteers receiving a single oral dose of a novel formulation for improved absorption
- (2018) Maria Loose et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Clinical activity of ceftazidime/avibactam against MDR Enterobacteriaceae and Pseudomonas aeruginosa: pooled data from the ceftazidime/avibactam Phase III clinical trial programme
- (2018) Gregory G Stone et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- OUP accepted manuscript
- (2018) JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Eradication of early P. aeruginosa infection in children
- (2018) Felix Ratjen et al. Journal of Cystic Fibrosis
- KB001-A, a novel anti-inflammatory, found to be safe and well-tolerated in cystic fibrosis patients infected with Pseudomonas aeruginosa
- (2018) R. Jain et al. Journal of Cystic Fibrosis
- The effects of antibiotic cycling and mixing on antibiotic resistance in intensive care units: a cluster-randomised crossover trial
- (2018) Pleun Joppe van Duijn et al. LANCET INFECTIOUS DISEASES
- Ceftazidime-avibactam versus meropenem in nosocomial pneumonia, including ventilator-associated pneumonia (REPROVE): a randomised, double-blind, phase 3 non-inferiority trial
- (2018) Antoni Torres et al. LANCET INFECTIOUS DISEASES
- Risk factors for mortality in patients with acute leukemia and bloodstream infections in the era of multiresistance
- (2018) Carolina Garcia-Vidal et al. PLoS One
- A Prospective Trial of Nebulized Amikacin in the Treatment of Bronchiectasis Exacerbation
- (2018) Yirepanjaing Ailiyaer et al. RESPIRATION
- Early increase of VEGF-A is associated with resolution of ventilator-associated pneumonia: Clinical and experimental evidence
- (2018) Ioannis Strouvalis et al. RESPIROLOGY
- Pyoverdine, a siderophore from Pseudomonas aeruginosa, translocates into C. elegans, removes iron, and activates a distinct host response
- (2018) Donghoon Kang et al. Virulence
- Targeted disruption of the extracellular polymeric network of Pseudomonas aeruginosa biofilms by alginate oligosaccharides
- (2018) Lydia C. Powell et al. npj Biofilms and Microbiomes
- Phase 1 study of MEDI3902, an investigational anti–Pseudomonas aeruginosa PcrV and Psl bispecific human monoclonal antibody, in healthy adults
- (2018) S.O. Ali et al. CLINICAL MICROBIOLOGY AND INFECTION
- Metagenome analysis of Russian and Georgian Pyophage cocktails and a placebo-controlled safety trial of single phage versus phage cocktail in healthy Staphylococcus aureus carriers
- (2018) Shawna McCallin et al. ENVIRONMENTAL MICROBIOLOGY
- Pseudomonas aeruginosa bacteremia: resistance to antibiotics, risk factors, and patient mortality
- (2018) Astra Vitkauskienė et al. Medicina-Lithuania
- Gallium disrupts bacterial iron metabolism and has therapeutic effects in mice and humans with lung infections
- (2018) Christopher H. Goss et al. Science Translational Medicine
- Small Molecule Inhibitor of Type Three Secretion System Belonging to a Class 2,4-disubstituted-4H-[1,3,4]-thiadiazine-5-ones Improves Survival and Decreases Bacterial Loads in an Airway Pseudomonas aeruginosa Infection in Mice
- (2018) Anna B. Sheremet et al. Biomed Research International
- Assessment of device-associated infection rates in four teaching hospitals, Islamic Republic of Iran
- (2018) Shirin Afhami et al. EASTERN MEDITERRANEAN HEALTH JOURNAL
- Single-Center Evaluation of the Pharmacokinetics of WCK 5222 (Cefepime-Zidebactam Combination) in Subjects with Renal Impairment
- (2018) Richard A. Preston et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies
- (2018) Zheng Pang et al. BIOTECHNOLOGY ADVANCES
- Multidrug resistant Pseudomonas aeruginosa in Estonian hospitals
- (2018) Kaidi Telling et al. BMC INFECTIOUS DISEASES
- Cefiderocol versus imipenem-cilastatin for the treatment of complicated urinary tract infections caused by Gram-negative uropathogens: a phase 2, randomised, double-blind, non-inferiority trial
- (2018) Simon Portsmouth et al. LANCET INFECTIOUS DISEASES
- Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1/2 trial
- (2018) Patrick Jault et al. LANCET INFECTIOUS DISEASES
- Changes in Prevalence of Health Care–Associated Infections in U.S. Hospitals
- (2018) Shelley S. Magill et al. NEW ENGLAND JOURNAL OF MEDICINE
- The efficacy and safety of tazobactam/ceftolozane in combination with metronidazole in Japanese patients with complicated intra-abdominal infections
- (2018) Hiroshige Mikamo et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Maximally effective dosing regimens of meropenem in patients with septic shock
- (2017) Fredrik Sjövall et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Reduced survival in adult cystic fibrosis despite attenuated lung function decline
- (2017) Claire Keating et al. Journal of Cystic Fibrosis
- Bloodstream infections in pediatric patients with acute leukemia: Emphasis on gram-negative bacteria infections
- (2017) Fu-Chun Kuo et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- The Mla pathway is critical for Pseudomonas aeruginosa resistance to outer membrane permeabilization and host innate immune clearance
- (2017) Jason Munguia et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Evolution of Stenotrophomonas maltophilia in Cystic Fibrosis Lung over Chronic Infection: A Genomic and Phenotypic Population Study
- (2017) Alfonso Esposito et al. Frontiers in Microbiology
- Microbiology in burns patients with blood stream infections: trends over time and during the course of hospitalization
- (2017) Dolores Sousa et al. Infectious Diseases
- Early childhood lung function is a stronger predictor of adolescent lung function in cystic fibrosis than early Pseudomonas aeruginosa infection
- (2017) Jessica E. Pittman et al. PLoS One
- A High-Affinity Native Human Antibody Disrupts Biofilm from Staphylococcus aureus Bacteria and Potentiates Antibiotic Efficacy in a Mouse Implant Infection Model
- (2016) Angeles Estellés et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Surveillance of antibiotic susceptibility in a Swedish Burn Center 1994–2012
- (2016) Jian Fransén et al. BURNS
- Role of CFTR in epithelial physiology
- (2016) Vinciane Saint-Criq et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- A Case-Control Study Assessing the Impact of Nonventilated Hospital-Acquired Pneumonia on Patient Outcomes
- (2016) Scott T. Micek et al. CHEST
- Major Transcriptome Changes Accompany the Growth of Pseudomonas aeruginosa in Blood from Patients with Severe Thermal Injuries
- (2016) Cassandra Kruczek et al. PLoS One
- Targeting the Type Three Secretion System in Pseudomonas aeruginosa
- (2016) Ahalieyah Anantharajah et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Pseudomonas aeruginosa proteolytically alters the interleukin 22-dependent lung mucosal defense
- (2016) Antoine Guillon et al. Virulence
- Vital Signs: Preventing Antibiotic-Resistant Infections in Hospitals — United States, 2014
- (2016) Lindsey M. Weiner et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- IgM-Enriched Immunoglobulin Attenuates Systemic Endotoxin Activity in Early Severe Sepsis: A Before-After Cohort Study
- (2016) Saskia Wand et al. PLoS One
- Clinical applications of pulmonary delivery of antibiotics
- (2015) Patrick A. Flume et al. ADVANCED DRUG DELIVERY REVIEWS
- Disarming Pseudomonas aeruginosa Virulence Factor LasB by Leveraging a Caenorhabditis elegans Infection Model
- (2015) Jie Zhu et al. CHEMISTRY & BIOLOGY
- Current epidemiology and antimicrobial resistance data for bacterial bloodstream infections in patients with hematologic malignancies: an Italian multicentre prospective survey
- (2015) E.M. Trecarichi et al. CLINICAL MICROBIOLOGY AND INFECTION
- Healthcare-Associated Infections in Pediatric Intensive Care Units in Turkey: a National Point-Prevalence Survey
- (2015) Eda Kepenekli et al. JAPANESE JOURNAL OF INFECTIOUS DISEASES
- Pseudomonas aeruginosaExoT Induces Mitochondrial Apoptosis in Target Host Cells in a Manner That Depends on Its GTPase-activating Protein (GAP) Domain Activity
- (2015) Stephen J. Wood et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Small Molecule Disruption of Quorum Sensing Cross-Regulation in Pseudomonas aeruginosa Causes Major and Unexpected Alterations to Virulence Phenotypes
- (2015) Michael A. Welsh et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Composition, function, and regulation of T6SS in Pseudomonas aeruginosa
- (2015) Lihua Chen et al. MICROBIOLOGICAL RESEARCH
- Risk factors for pre- and post-engraftment bloodstream infections after allogeneic hematopoietic stem cell transplantation
- (2015) M. Kikuchi et al. Transplant Infectious Disease
- Clinical outcomes associated with Staphylococcus aureus and Pseudomonas aeruginosa airway infections in adult cystic fibrosis patients
- (2015) Heather G. Ahlgren et al. BMC Pulmonary Medicine
- Correction: The Role of ExoS in Dissemination of Pseudomonas aeruginosa during Pneumonia
- (2015) Stephanie M. Rangel et al. PLoS Pathogens
- Pseudomonas Exotoxin A: optimized by evolution for effective killing
- (2015) Marta Michalska et al. Frontiers in Microbiology
- Contribution of the platelet activating factor signaling pathway to cerebral microcirculatory dysfunction during experimental sepsis by ExoU producingPseudomonas aeruginosa
- (2015) Maria Cristina Plotkowski et al. Pathogens and Disease
- How to treat VAP due to MDR pathogens in ICU patients
- (2014) José Garnacho-Montero et al. BMC INFECTIOUS DISEASES
- Global Prospective Epidemiologic and Surveillance Study of Ventilator-Associated Pneumonia due to Pseudomonas aeruginosa*
- (2014) Marin H. Kollef et al. CRITICAL CARE MEDICINE
- Assessment of panobacumab as adjunctive immunotherapy for the treatment of nosocomial Pseudomonas aeruginosa pneumonia
- (2014) Y.-A. Que et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Nitrite modulates bacterial antibiotic susceptibility and biofilm formation in association with airway epithelial cells
- (2014) Anna C. Zemke et al. FREE RADICAL BIOLOGY AND MEDICINE
- Viruses versus bacteria--novel approaches to phage therapy as a tool against multidrug-resistant pathogens
- (2014) T. M. Viertel et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Impact of peri-transplant vancomycin and fluoroquinolone administration on rates of bacteremia in allogeneic hematopoietic stem cell transplant (HSCT) recipients: A 12-year single institution study
- (2014) Susan K. Seo et al. JOURNAL OF INFECTION
- The emergence of vancomycin-resistant enterococcal bacteremia in hematopoietic stem cell transplant recipients
- (2014) Michael J. Satlin et al. LEUKEMIA & LYMPHOMA
- Bloodstream Infections in Patients With Solid Tumors
- (2014) Mar Marín et al. MEDICINE
- The protective effects of IgM-enriched immunoglobulin and erythropoietin on the lung and small intestine tissues of rats with induced sepsis: Biochemical and histopathological evaluation
- (2014) Irem Ates et al. PHARMACEUTICAL BIOLOGY
- A multifunctional bispecific antibody protects against Pseudomonas aeruginosa
- (2014) A. DiGiandomenico et al. Science Translational Medicine
- The ADP-Ribosyltransferase Domain of the Effector Protein ExoS Inhibits Phagocytosis of Pseudomonas aeruginosa during Pneumonia
- (2014) S. M. Rangel et al. mBio
- Respiratory infections in patients undergoing mechanical ventilation
- (2014) Jordi Rello et al. Lancet Respiratory Medicine
- Nosocomial infection characteristics in a burn intensive care unit: Analysis of an eleven-year active surveillance
- (2013) Oral Öncül et al. BURNS
- Season is associated with Pseudomonas aeruginosa acquisition in young children with cystic fibrosis
- (2013) K.J. Psoter et al. CLINICAL MICROBIOLOGY AND INFECTION
- Inhaled antibiotics for the treatment of chronic bronchopulmonaryPseudomonas aeruginosainfection in cystic fibrosis: systematic review of randomised controlled trials
- (2013) Luis Máiz et al. EXPERT OPINION ON PHARMACOTHERAPY
- Anti-PcrV antibody in cystic fibrosis: A novel approach targetingPseudomonas aeruginosaairway infection
- (2013) Carlos E. Milla et al. PEDIATRIC PULMONOLOGY
- A randomized, placebo-controlled phase I study assessing the safety and immunogenicity of aPseudomonas aeruginosahybrid outer membrane protein OprF/I vaccine (IC43) in healthy volunteers
- (2013) Kerstin Westritschnig et al. Human Vaccines & Immunotherapeutics
- Prevalence and antimicrobial susceptibility of respiratory pathogens in patients with cystic fibrosis
- (2012) Vilma Almeida Paixão et al. Brazilian Journal of Infectious Diseases
- Phenotypes selected during chronic lung infection in cystic fibrosis patients: implications for the treatment ofPseudomonas aeruginosabiofilm infections
- (2012) Oana Ciofu et al. FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY
- Treatment of lung infection in patients with cystic fibrosis: Current and future strategies
- (2012) Gerd Döring et al. Journal of Cystic Fibrosis
- Identification of broadly protective human antibodies toPseudomonas aeruginosaexopolysaccharide Psl by phenotypic screening
- (2012) Antonio DiGiandomenico et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Pseudomonas aeruginosa Pili and Flagella Mediate Distinct Binding and Signaling Events at the Apical and Basolateral Surface of Airway Epithelium
- (2012) Iwona Bucior et al. PLoS Pathogens
- Fosfomycin/Tobramycin for Inhalation in Patients with Cystic Fibrosis withPseudomonasAirway Infection
- (2011) Bruce C. Trapnell et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Role of Exopolysaccharides in Pseudomonas aeruginosa Biofilm Formation and Architecture
- (2011) Aamir Ghafoor et al. APPLIED AND ENVIRONMENTAL MICROBIOLOGY
- Cystic Fibrosis Transmembrane Conductance Regulator Intracellular Processing, Trafficking, and Opportunities for Mutation-Specific Treatment
- (2011) Mark P. Rogan et al. CHEST
- Pharmacokinetics and safety of panobacumab: specific adjunctive immunotherapy in critical patients with nosocomial Pseudomonas aeruginosa O11 pneumonia
- (2011) Q. Lu et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Prosthetic Joint Infection Caused by Gram-Negative Organisms
- (2011) Benjamin Zmistowski et al. JOURNAL OF ARTHROPLASTY
- Pseudomonas aeruginosa Alkaline Protease Blocks Complement Activation via the Classical and Lectin Pathways
- (2011) A. J. Laarman et al. JOURNAL OF IMMUNOLOGY
- A Novel Polymyxin Derivative That Lacks the Fatty Acid Tail and Carries Only Three Positive Charges Has Strong Synergism with Agents Excluded by the Intact Outer Membrane
- (2010) M. Vaara et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Sodium Nitrite-Mediated Killing of the Major Cystic Fibrosis Pathogens Pseudomonas aeruginosa, Staphylococcus aureus, and Burkholderia cepacia under Anaerobic Planktonic and Biofilm Conditions
- (2010) T. A. Major et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Changing Microbial Epidemiology in Cystic Fibrosis
- (2010) J. J. LiPuma CLINICAL MICROBIOLOGY REVIEWS
- Pseudomonas aeruginosa Cytotoxin ExoU Is Injected into Phagocytic Cells during Acute Pneumonia
- (2010) M. H. Diaz et al. INFECTION AND IMMUNITY
- Full Virulence ofPseudomonas aeruginosaRequires OprF
- (2010) Laurène Fito-Boncompte et al. INFECTION AND IMMUNITY
- Protein secretion systems in Pseudomonas aeruginosa: A wealth of pathogenic weapons
- (2010) Sophie Bleves et al. INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY
- Extracellular enzymes affect biofilm formation of mucoid Pseudomonas aeruginosa
- (2010) P. Tielen et al. MICROBIOLOGY-SGM
- Hospital-Acquired Infections Due to Gram-Negative Bacteria
- (2010) Anton Y. Peleg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Return of FEV1after pulmonary exacerbation in children with cystic fibrosis
- (2010) Don B. Sanders et al. PEDIATRIC PULMONOLOGY
- Quorum Sensing Inhibition Selects for Virulence and Cooperation in Pseudomonas aeruginosa
- (2010) Thilo Köhler et al. PLoS Pathogens
- Blood Stream Infections in Allogeneic Hematopoietic Stem Cell Transplant Recipients: Reemergence of Gram-Negative Rods and Increasing Antibiotic Resistance
- (2009) Malgorzata Mikulska et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Gram‐Negative Prosthetic Joint Infections: Risk Factors and Outcome of Treatment
- (2009) Pang‐Hsin Hsieh et al. CLINICAL INFECTIOUS DISEASES
- Antibacterial activities of a fosfomycin/tobramycin combination: a novel inhaled antibiotic for bronchiectasis
- (2009) D. L. MacLeod et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Aminoglycoside therapy against Pseudomonas aeruginosa in cystic fibrosis: A review
- (2009) Felix Ratjen et al. Journal of Cystic Fibrosis
- Crystal Structure of the LasA Virulence Factor from Pseudomonas aeruginosa: Substrate Specificity and Mechanism of M23 Metallopeptidases
- (2009) James Spencer et al. JOURNAL OF MOLECULAR BIOLOGY
- The type III secretion system of Pseudomonas aeruginosa: infection by injection
- (2009) Alan R. Hauser NATURE REVIEWS MICROBIOLOGY
- Incidence of Pseudomonas aeruginosa Bacteremia: A Population-Based Study
- (2008) Majdi N. Al-Hasan et al. AMERICAN JOURNAL OF MEDICINE
- Effects of Antibiotics on Quorum Sensing in Pseudomonas aeruginosa
- (2008) M. E. Skindersoe et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Polymicrobial Prosthetic Joint Infections: Risk Factors and Outcome
- (2008) Camelia E. Marculescu et al. CLINICAL ORTHOPAEDICS AND RELATED RESEARCH
- Dynamics of Pseudomonas aeruginosa genome evolution
- (2008) K. Mathee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started